How are the liver and cholesterol connected?
Last content review 2026-09-23
The short answer
The liver makes cholesterol, packages it into lipoproteins and clears LDL from the blood. In metabolic liver disease the typical pattern is raised triglycerides, lower HDL and small dense LDL particles — a profile associated with cardiovascular risk.
What is happening?
Hepatic VLDL production rises when the liver is handling excess fatty acids and carbohydrate.
LDL receptor activity and lipid clearance are influenced by insulin signalling and thyroid hormone, among other factors.
Why does this matter?
People often assume statins are unsafe with a fatty liver. Current guidance states that statins are generally not contraindicated in MASLD and can be used where cardiovascular risk warrants, under medical supervision.
Never start or stop a lipid-lowering medicine on your own.
What does the evidence say?
AASLD and EASL guidance support statin use in people with MASLD when indicated for cardiovascular risk, with usual clinical monitoring.
Key takeaway
Fatty liver and abnormal lipids usually travel together — and treating cholesterol is a medical decision, not a self-managed one.
Sources & references
American Association for the Study of Liver Diseases
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease (2023) · Clinical guideline
View original sourceEASL, EASD and EASO
EASL–EASD–EASO Clinical Practice Guideline on MASLD (2024) · Clinical guideline
View original source
This page is general health education. It is not a diagnosis, and it cannot replace advice from your treating doctor. Never start or stop a prescribed medicine based on what you read here.
Related facts
Browse the LivRx FAQ →If this applies to you, a structured assessment with a qualified doctor is the appropriate next step.
Book an Assessment